Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)

SHE:300181 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	731.33	804.67	931.98	1,082	232.3	253.75
Trading Asset Securities	-	-	151	10.83	65.52	61.04
Cash & Short-Term Investments	731.33	804.67	1,083	1,093	297.82	314.79
Cash Growth	-21.02%	-25.70%	-0.91%	266.97%	-5.39%	126.93%
Accounts Receivable	823.89	783.33	532.42	510.07	337.33	308.18
Other Receivables	236.97	18.18	9.02	24.42	26.77	5.9
Receivables	1,061	801.52	541.44	534.5	364.1	314.08
Inventory	480.66	523.75	426.52	318.83	273.59	201.44
Prepaid Expenses	0	0	-	7.87	-	-
Other Current Assets	25.34	47.51	5.53	5.45	6.16	135.07
Total Current Assets	2,298	2,177	2,056	1,960	941.67	965.38
Property, Plant & Equipment	1,325	1,220	1,060	972.41	806.32	750.09
Long-Term Investments	630.07	254.64	179.7	392.36	650.67	463
Goodwill	130.32	130.32	130.32	130.32	130.32	130.32
Other Intangible Assets	73.17	75.08	71.27	63.04	64.89	70.2
Long-Term Deferred Tax Assets	31.5	30.4	25.5	25.14	15.51	14.41
Long-Term Deferred Charges	40.57	35.58	25.49	25.42	25.6	23.11
Other Long-Term Assets	70.71	68.91	78.07	74.76	113.55	53.37
Total Assets	4,599	3,992	3,627	3,643	2,749	2,470
Accounts Payable	506.35	482.41	433.85	468.88	296.77	200.63
Accrued Expenses	77.32	86.53	82.24	78.32	62.33	49.85
Short-Term Debt	570.2	377.31	193.06	138.16	178.2	302.85
Current Portion of Long-Term Debt	0.04	0.03	10.01	0.01	-	15.02
Current Portion of Leases	3.02	3.32	2.49	2.83	4.21	-
Current Income Taxes Payable	58.3	52.54	32.65	26.59	16.46	7.3
Current Unearned Revenue	10.41	14.45	2.23	14.14	3.06	1.56
Other Current Liabilities	39.66	39.46	38.28	26	23.55	21.83
Total Current Liabilities	1,265	1,056	794.83	754.94	584.58	599.04
Long-Term Debt	51.66	30.66	-	10	-	30.05
Long-Term Leases	17.8	18.27	16.69	22.13	24.27	-
Long-Term Unearned Revenue	28.14	26.5	19.9	19.76	22.37	25.48
Long-Term Deferred Tax Liabilities	129.63	41.03	21.68	76.24	134.1	95.86
Total Liabilities	1,493	1,173	853.09	883.07	765.31	750.43
Common Stock	701.39	701.39	701.39	701.39	608.62	608.62
Additional Paid-In Capital	1,118	1,135	1,135	1,135	340.48	340.48
Retained Earnings	998.68	1,041	849.32	676.8	525.52	396.19
Treasury Stock	-122.15	-203.97	-	-	-	-
Comprehensive Income & Other	342.33	94.63	42.66	190.19	369.44	257.52
Total Common Equity	3,038	2,769	2,729	2,704	1,844	1,603
Minority Interest	68.66	50.56	45.2	56.18	139.15	116.63
Shareholders' Equity	3,107	2,819	2,774	2,760	1,983	1,719
Total Liabilities & Equity	4,599	3,992	3,627	3,643	2,749	2,470
Total Debt	642.71	429.59	222.25	173.13	206.67	347.92
Net Cash (Debt)	88.62	375.08	860.73	919.77	91.15	-33.13
Net Cash Growth	-86.68%	-56.42%	-6.42%	909.09%	-	-
Net Cash Per Share	0.13	0.54	1.24	1.52	0.15	-0.05
Filing Date Shares Outstanding	692.47	692.47	701.39	701.39	608.62	608.62
Total Common Shares Outstanding	692.47	686.49	701.39	701.39	608.62	608.62
Working Capital	1,033	1,121	1,262	1,205	357.1	366.33
Book Value Per Share	4.39	4.03	3.89	3.85	3.03	2.63
Tangible Book Value	2,835	2,563	2,527	2,510	1,649	1,402
Tangible Book Value Per Share	4.09	3.73	3.60	3.58	2.71	2.30
Buildings	1,025	1,014	962.71	832.63	678.11	660.12
Machinery	573.21	529.12	467.55	432.59	412.82	395.27
Construction In Progress	245.69	161.43	61.14	78.06	40.29	0.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.